# The Safety and Efficacy of Enhanced Recovery After Surgery on Clinical and Immune Outcomes for Gynecological Oncology

> **NCT03640299** · NA · UNKNOWN · sponsor: **Shanghai First Maternity and Infant Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Gynecologic Cancer

## Interventions

- **PROCEDURE:** ERAS procedure

## Key facts

- **NCT ID:** NCT03640299
- **Lead sponsor:** Shanghai First Maternity and Infant Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-30
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03640299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03640299, "The Safety and Efficacy of Enhanced Recovery After Surgery on Clinical and Immune Outcomes for Gynecological Oncology". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03640299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*